{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:07:53Z","timestamp":1793196473388,"version":"4.5.0"},"reference-count":64,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T00:00:00Z","timestamp":1757548800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","diabetesresearchclinicalpractice.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Diabetes Research and Clinical Practice"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.diabres.2025.112480","type":"journal-article","created":{"date-parts":[[2025,9,12]],"date-time":"2025-09-12T06:55:44Z","timestamp":1757660144000},"page":"112480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy"],"prefix":"10.1016","volume":"229","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4303-3243","authenticated-orcid":false,"given":"Jorge","family":"Acosta-Reyes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana Patricia","family":"Rodr\u00edguez Garrido","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Acosta Vergara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Aschner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina Alejandra","family":"Fraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aitana","family":"Vazquez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3424-0745","authenticated-orcid":false,"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.diabres.2025.112480_b0005","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.diabres.2018.02.023","article-title":"IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045","volume":"138","author":"Cho","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.diabres.2025.112480_b0010","unstructured":"International Diabetes Federation. IDF Diabetes Atlas 10th edition scientific committee. IDF Diabetes Atlas. Brussels: International Diabetes Federation\u00a9; 2021."},{"key":"10.1016\/j.diabres.2025.112480_b0015","doi-asserted-by":"crossref","unstructured":"Glucose tolerance and mortality: comparison of WHO and American Diabetes Association diagnostic criteria. The DECODE study group. European Diabetes Epidemiology Group. Diabetes Epidemiology: Collaborative analysis Of Diagnostic criteria in Europe. Lancet. 1999;354(9179):617-621.","DOI":"10.1016\/S0140-6736(98)12131-1"},{"key":"10.1016\/j.diabres.2025.112480_b0020","doi-asserted-by":"crossref","unstructured":"DECODE Study Group, European Diabetes Epidemiology Group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases?. Diabetes Care. 2003;26(3):688-696.","DOI":"10.2337\/diacare.26.3.688"},{"issue":"5","key":"10.1016\/j.diabres.2025.112480_b0025","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.3390\/jcm12051876","article-title":"Type 2 Diabetes Prevention Programs-from Proof-of-Concept Trials to National Intervention and beyond","volume":"12","author":"Tuomilehto","year":"2023","journal-title":"J Clin Med"},{"issue":"13","key":"10.1016\/j.diabres.2025.112480_b0030","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1001\/jama.281.13.1203","article-title":"Relationship between fasting plasma glucose and glycosylated hemoglobin: potential for false-positive diagnoses of type 2 diabetes using new diagnostic criteria [published correction appears in JAMA 1999 Jun 16;281(23):2187]","volume":"281","author":"Davidson","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.diabres.2025.112480_b0035","unstructured":"Classification of diabetes mellitus. Geneve: World Health Organization., 2019."},{"issue":"3","key":"10.1016\/j.diabres.2025.112480_b0040","doi-asserted-by":"crossref","first-page":"725","DOI":"10.2337\/diacare.26.3.725","article-title":"The diabetes risk score: a practical tool to predict type 2 diabetes risk","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"issue":"11","key":"10.1016\/j.diabres.2025.112480_b0045","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.medcli.2010.01.015","article-title":"Declaraci\u00f3n PRISMA: una propuesta para mejorar la publicaci\u00f3n de revisiones sistem\u00e1ticas y metaan\u00e1lisis [PRISMA declaration: a proposal to improve the publication of systematic reviews and meta-analyses]","volume":"135","author":"Urr\u00fatia","year":"2010","journal-title":"Med Clin (Barc)"},{"key":"10.1016\/j.diabres.2025.112480_b0050","doi-asserted-by":"crossref","unstructured":"Deeks J, Bossuyt P, Leeflang M, Takwoingi Y. Cochrane Handbook for Systematic Reviews of Diagnostic Test Accuracy . Version 2.0 (updated July 2023). Cochrane; 2023.","DOI":"10.1002\/14651858.ED000163"},{"key":"10.1016\/j.diabres.2025.112480_b0055","doi-asserted-by":"crossref","unstructured":"McInnes MDF, Moher D, Thombs BD, et al. Preferred Reporting Items for a Systematic Review and Meta-analysis of Diagnostic Test Accuracy Studies: The PRISMA-DTA Statement [published correction appears in JAMA. 2019 Nov 26;322(20):2026. doi: 10.1001\/jama.2019.18307]. JAMA. 2018;319(4):388-396.","DOI":"10.1001\/jama.2017.19163"},{"issue":"6","key":"10.1016\/j.diabres.2025.112480_b0060","doi-asserted-by":"crossref","first-page":"e61","DOI":"10.2337\/dc11-9998","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"34","author":"Sacks","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/j.diabres.2025.112480_b0065","unstructured":"Higgins J, Green S. Cochrane Handbook for Systematic Reviews of Interventions 5.1.0 [updated March 2011]2011."},{"issue":"8","key":"10.1016\/j.diabres.2025.112480_b0070","doi-asserted-by":"crossref","first-page":"529","DOI":"10.7326\/0003-4819-155-8-201110180-00009","article-title":"QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies","volume":"155","author":"Whiting","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.diabres.2025.112480_b0075","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ, Oxman AD, Brozek J, et al. Grading quality of evidence and strength of recommendations for diagnostic tests and strategies [published correction appears in BMJ. 2008 May 24;336(7654).","DOI":"10.1136\/bmj.a139"},{"key":"10.1016\/j.diabres.2025.112480_b0080","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jclinepi.2019.12.020","article-title":"GRADE guidelines: 21 part 1. Study design, risk of bias, and indirectness in rating the certainty across a body of evidence for test accuracy","volume":"122","author":"Sch\u00fcnemann","year":"2020","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2025.112480_b0085","doi-asserted-by":"crossref","unstructured":"Sch\u00fcnemann HJ, Mustafa RA, Brozek J, et al. GRADE guidelines: 21 part 2. Test accuracy: inconsistency, imprecision, publication bias, and other domains for rating the certainty of evidence and presenting it in evidence profiles and summary of findings tables. J Clin Epidemiol. 2020;122:142-152.","DOI":"10.1016\/j.jclinepi.2019.12.021"},{"key":"10.1016\/j.diabres.2025.112480_b0090","unstructured":"Review Manager(RevMan) [Computer program]. Version 5.4.: The Cochrane Collaboration; 2020."},{"issue":"10","key":"10.1016\/j.diabres.2025.112480_b0095","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.jclinepi.2005.02.022","article-title":"Bivariate analysis of sensitivity and specificity produces informative summary measures in diagnostic reviews","volume":"58","author":"Reitsma","year":"2005","journal-title":"J Clin Epidemiol"},{"issue":"14","key":"10.1016\/j.diabres.2025.112480_b0100","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1002\/sim.4780121403","article-title":"Combining independent studies of a diagnostic test into a summary ROC curve: data-analytic approaches and some additional considerations","volume":"12","author":"Moses","year":"1993","journal-title":"Stat Med"},{"issue":"11","key":"10.1016\/j.diabres.2025.112480_b0105","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/S0895-4356(03)00177-X","article-title":"The diagnostic odds ratio: a single indicator of test performance","volume":"56","author":"Glas","year":"2003","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/j.diabres.2025.112480_b0110","doi-asserted-by":"crossref","unstructured":"Gabriel R, Acosta T, Florez K, et al. Validation of the Finnish Type 2 Diabetes Risk Score (FINDRISC) with the OGTT in Health Care Practices in Europe. Diabetes Res Clin Pract 2021;178:108976. (In eng). DOI: 10.1016\/j.diabres.2021.108976.","DOI":"10.1016\/j.diabres.2021.108976"},{"key":"10.1016\/j.diabres.2025.112480_b0115","doi-asserted-by":"crossref","first-page":"403","DOI":"10.2147\/DMSO.S35545","article-title":"Frequency of diabetes, impaired fasting glucose, and glucose intolerance in high-risk groups identified by a FINDRISC survey in Puebla City","volume":"5","author":"Garc\u00eda-Alcal\u00e1","year":"2012","journal-title":"Mexico Diabetes Metab Syndr Obes"},{"key":"10.1016\/j.diabres.2025.112480_b0120","doi-asserted-by":"crossref","unstructured":"Zhang L, Zhang Z, Zhang Y, Hu G, Chen L. Evaluation of Finnish Diabetes Risk Score in screening undiagnosed diabetes and prediabetes among U.S. adults by gender and race: NHANES 1999-2010. PLoS One. 2014;9(5):e97865.","DOI":"10.1371\/journal.pone.0097865"},{"issue":"3","key":"10.1016\/j.diabres.2025.112480_b0125","article-title":"A novel testing model for opportunistic screening of pre-diabetes and diabetes among U.S. adults","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.diabres.2025.112480_b0130","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabet.2011.11.007","article-title":"Use of clinical scores to detect dysglycaemia in overweight or obese women","volume":"38","author":"Cosson","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1016\/j.diabres.2025.112480_b0135","unstructured":"Chacko S, Boesch CC, Mamas MA, Gow J, Bowell S, Neyses L. The Finnish diabetes risk score (FINDRISC) predicts impaired glucose tolerance in a heart failure population. Eur J Heart Failure. 2009;8:ii580-ii581, Supplement."},{"key":"10.1016\/j.diabres.2025.112480_b0140","first-page":"31","article-title":"Screening for diabetes and impaired glucose regulation in a community setting: Comparison of eight strategies using routine data, self assessment risk scores, fasting glucose and HbAlc","volume":"26","author":"Khunti","year":"2009","journal-title":"Diabet Med"},{"issue":"5","key":"10.1016\/j.diabres.2025.112480_b0145","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1007\/s00125-010-1990-7","article-title":"The Evaluation of Screening and Early Detection strategies for Type 2 Diabetes and Impaired Glucose Tolerance (DETECT-2) update of the finnish diabetes risk score for prediction of incident type 2 diabetes","volume":"54","author":"Alssema","year":"2011","journal-title":"Diabetologia"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0150","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/phn.12380","article-title":"Translation and validation of the Canadian diabetes risk assessment questionnaire in China","volume":"35","author":"Guo","year":"2018","journal-title":"Public Health Nurs"},{"key":"10.1016\/j.diabres.2025.112480_b0155","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.725314","article-title":"Comparison of the finnish Diabetes Risk score Model with the Metabolic Syndrome in a Shanghai Population","volume":"13","author":"Jin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"6","key":"10.1016\/j.diabres.2025.112480_b0160","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.pcd.2017.07.003","article-title":"Evaluating FINDRISC as a screening tool for type 2 diabetes among overweight adults in the PREVIEW:NZ cohort","volume":"11","author":"Silvestre","year":"2017","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0165","first-page":"87","article-title":"Le score FINDRISK pr\u00e9dit une dysglyc\u00e9mie m\u00e9connue","volume":"11","author":"Belhadj-Mostefa","year":"2017","journal-title":"Influence du sexe Med Mal Metab"},{"key":"10.1016\/j.diabres.2025.112480_b0170","first-page":"532","article-title":"Contribution of the finnish risk score (FINDRISC) for identifying dysglycemia in an Algiers' population","volume":"8","author":"Azzouz","year":"2014","journal-title":"Algeria Med Mal Metab"},{"issue":"6","key":"10.1016\/j.diabres.2025.112480_b0175","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jdiacomp.2016.05.004","article-title":"Screening for type 2 diabetes mellitus in overweight and obese subjects made easy by the FINDRISC score","volume":"30","author":"Meijnikman","year":"2016","journal-title":"J Diabetes Complications"},{"issue":"7","key":"10.1016\/j.diabres.2025.112480_b0180","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0158489","article-title":"Performance of the finnish Diabetes Risk score and a Simplified finnish Diabetes Risk score in a Community-based, Cross-Sectional Programme for Screening of Undiagnosed Type 2 Diabetes Mellitus and Dysglycaemia in Madrid, Spain: the SPREDIA-2 Study","volume":"11","author":"Salinero-Fort","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.diabres.2025.112480_b0185","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1741-7015-11-45","article-title":"Shifting from glucose diagnosis to the new HbA1c diagnosis reduces the capability of the finnish Diabetes Risk score (FINDRISC) to screen for glucose abnormalities within a real-life primary healthcare preventive strategy","volume":"11","author":"Costa","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/j.diabres.2025.112480_b0190","doi-asserted-by":"crossref","unstructured":"Soriguer F, Vald\u00e9s S, Tapia MJ, et al. Validaci\u00f3n del FINDRISC (FINnish Diabetes Risk SCore) para la predicci\u00f3n del riesgo de diabetes tipo 2 en una poblaci\u00f3n del sur de Espa\u00f1a. Estudio Pizarra [Validation of the FINDRISC (FINnish Diabetes RIsk SCore) for prediction of the risk of type 2 diabetes in a population of southern Spain. Pizarra Study]. Med Clin (Barc). 2012;138(9):371-376.","DOI":"10.1016\/j.medcli.2011.05.025"},{"key":"10.1016\/j.diabres.2025.112480_b0305","first-page":"15","article-title":"Validation of the findrisc questionnaire in the spanish population: the viva (variability of insulin with visceral adiposity) cohort study","volume":"5","author":"Gabriel","year":"2013","journal-title":"J Diabetes"},{"issue":"12","key":"10.1016\/j.diabres.2025.112480_b0195","first-page":"1501","article-title":"Feasibility of the FINDRISC questionnaire to identify individuals with impaired glucose tolerance in swedish primary care","volume":"29","author":"Hellgren","year":"2012","journal-title":"A cross-sectional population-based study Diabet Med"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0200","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.diabres.2010.12.020","article-title":"Evaluation of the finnish Diabetes Risk score as a screening tool for impaired fasting glucose, impaired glucose tolerance and undetected diabetes","volume":"92","author":"Tankova","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"10.1016\/j.diabres.2025.112480_b0205","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.diabet.2010.09.006","article-title":"Validation of the finnish diabetes risk score (FINDRISC) questionnaire for screening for undiagnosed type 2 diabetes, dysglycaemia and the metabolic syndrome in Greece","volume":"37","author":"Makrilakis","year":"2011","journal-title":"Diabetes Metab"},{"issue":"2","key":"10.1016\/j.diabres.2025.112480_b0210","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3132\/dvdr.2005.011","article-title":"Cross-sectional evaluation of the finnish Diabetes Risk score: a tool to identify undetected type 2 diabetes, abnormal glucose tolerance and metabolic syndrome","volume":"2","author":"Saaristo","year":"2005","journal-title":"Diab Vasc Dis Res"},{"issue":"6","key":"10.1016\/j.diabres.2025.112480_b0215","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.pcd.2018.07.015","article-title":"Diagnostic accuracy of the finnish Diabetes Risk score (FINDRISC) for undiagnosed T2DM in peruvian population","volume":"12","author":"Bernabe-Ortiz","year":"2018","journal-title":"Prim Care Diabetes"},{"issue":"8","key":"10.1016\/j.diabres.2025.112480_b0220","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299674","article-title":"External validation of finnish diabetes risk score (FINDRISC) and Latin American FINDRISC for screening of undiagnosed dysglycemia: Analysis in a peruvian hospital health care workers sample","volume":"19","author":"Yovera-Aldana","year":"2024","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0225","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000769","article-title":"Validity of the FINDRISC as a prediction tool for diabetes in a contemporary norwegian population: a 10-year follow-up of the HUNT study","volume":"7","author":"J\u00f8lle","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"Supplement 1","key":"10.1016\/j.diabres.2025.112480_b0230","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/S0939-4753(09)70081-X","article-title":"FINDRISC (finnish Diabetes Risk score): its use As a Predictor of both Diabetes Risk and Cardiovascular Risk in an Italian Population","volume":"19","author":"Penno","year":"2009","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.diabres.2025.112480_b0235","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13098-020-00590-8","article-title":"Diagnostic accuracy of the finnish Diabetes Risk score for the prediction of undiagnosed type 2 diabetes, prediabetes, and metabolic syndrome in the Lebanese University","volume":"12","author":"Abdallah","year":"2020","journal-title":"Diabetol Metab Syndr"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0240","first-page":"1","article-title":"Evaluaci\u00f3n del puntaje FINDRISC para detecci\u00f3n de prediabetes y diabetes tipo 2 sin diagn\u00f3stico [FINDRISC as screening for detection of prediabetes and unknown type 2 diabetes]","volume":"84","author":"Peralta","year":"2024","journal-title":"Medicina (B Aires)"},{"key":"10.1016\/j.diabres.2025.112480_b0295","first-page":"A15","article-title":"Screening for prediabetes, diabetes, metabolic syndrome and cardiovascular risk in overweight or obese subjects. Comparison of two clinical risk scores for diabetes occurrence","volume":"1","author":"Cosson","year":"2009","journal-title":"J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2025.112480_b0300","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.diabet.2010.02.004","article-title":"A large proportion of prediabetes and diabetes goes undiagnosed when only fasting plasma glucose and\/or HbA1c are measured in overweight or obese patients","volume":"36","author":"Cosson","year":"2010","journal-title":"Diabetes Metab"},{"issue":"4","key":"10.1016\/j.diabres.2025.112480_b0310","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.pcd.2014.10.009","article-title":"Primary care screening for individuals with impaired glucose metabolism with focus on impaired glucose tolerance","volume":"9","author":"Hellgren","year":"2015","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/j.diabres.2025.112480_b0245","doi-asserted-by":"crossref","unstructured":"Chen L, Magliano DJ, Balkau B, et al. AUSDRISK: an Australian Type 2 Diabetes Risk Assessment Tool based on demographic, lifestyle and simple anthropometric measures [published correction appears in Med J Aust. 2010 Mar 1;192(5):274]. Med J Aust. 2010;192(4):197-202.","DOI":"10.5694\/j.1326-5377.2010.tb03478.x"},{"issue":"4","key":"10.1016\/j.diabres.2025.112480_b0250","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/S1499-2671(09)34008-3","article-title":"Development of the CANRISK questionnaire to screen for prediabetes and undiagnosed type 2 diabetes","volume":"33","author":"Kaczorowski","year":"2009","journal-title":"Can J Diabetes"},{"issue":"4","key":"10.1016\/j.diabres.2025.112480_b0255","article-title":"Development and Validation of a Risk-score Model for Type 2 Diabetes: a Cohort Study of a Rural Adult Chinese Population","volume":"11","author":"Zhang","year":"2016","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0260","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.pcd.2016.09.004","article-title":"A Colombian diabetes risk score for detecting undiagnosed diabetes and impaired glucose regulation","volume":"11","author":"Barengo","year":"2017","journal-title":"Prim Care Diabetes"},{"issue":"3","key":"10.1016\/j.diabres.2025.112480_b0265","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.diabres.2007.01.013","article-title":"Diabetes risk score in Oman: a tool to identify prevalent type 2 diabetes among Arabs of the Middle East","volume":"77","author":"Al-Lawati","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"issue":"8","key":"10.1016\/j.diabres.2025.112480_b0270","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early Detection and Treatment of Type 2 Diabetes Reduce Cardiovascular Morbidity and Mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in people with Screen-Detected Diabetes in Primary Care (ADDITION-Europe)","volume":"38","author":"Herman","year":"2015","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.diabres.2025.112480_b0275","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.hjr.0000174793.31812.21","article-title":"The validity of the finnish Diabetes Risk score for the prediction of the incidence of coronary heart disease and stroke, and total mortality","volume":"12","author":"Silventoinen","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"issue":"6","key":"10.1016\/j.diabres.2025.112480_b0280","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3109\/07853890.2011.554428","article-title":"The finnish Diabetes Risk score (FINDRISC) as a screening tool for hepatic steatosis","volume":"43","author":"Carvalho","year":"2011","journal-title":"Ann Med"},{"key":"10.1016\/j.diabres.2025.112480_b0285","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108558","article-title":"The finnish Diabetes Risk score (FINDRISC), incident diabetes and low-grade inflammation","volume":"171","author":"Pesaro","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"issue":"10","key":"10.1016\/j.diabres.2025.112480_b0290","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1007\/s11136-013-0404-y","article-title":"The health-related quality-of-life impact of nocturnal awakenings in the middle-aged and older finnish population","volume":"22","author":"V\u00e4\u00e4t\u00e4inen","year":"2013","journal-title":"Qual Life Res"},{"issue":"6","key":"10.1016\/j.diabres.2025.112480_b0315","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.pcd.2019.04.006","article-title":"External validation of the finnish diabetes risk score in Venezuela using a national sample: the EVESCAM","volume":"13","author":"Nieto-Mart\u00ednez","year":"2019","journal-title":"Prim Care Diabetes"},{"issue":"1","key":"10.1016\/j.diabres.2025.112480_b0320","doi-asserted-by":"crossref","first-page":"19","DOI":"10.24095\/hpcdp.32.1.04","article-title":"Validating the CANRISK prognostic model for assessing diabetes risk in Canada's multi-ethnic population","volume":"32","author":"Robinson","year":"2011","journal-title":"Chronic Dis Inj Can"}],"container-title":["Diabetes Research and Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725004942?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168822725004942?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,25]],"date-time":"2025-11-25T14:18:55Z","timestamp":1764080335000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168822725004942"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":64,"alternative-id":["S0168822725004942"],"URL":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112480","relation":{},"ISSN":["0168-8227"],"issn-type":[{"value":"0168-8227","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finnish diabetes risk score (findrisc) for type 2 diabetes screening compared with the oral glucose tolerance test: A systematic review and meta-analysis of diagnostic test accuracy","name":"articletitle","label":"Article Title"},{"value":"Diabetes Research and Clinical Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.diabres.2025.112480","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"112480"}}